Joaquin Mateo

May 16, 2024 | diarioresponsable.com | Joaquin Mateo |David Santos |Iván Álvarez Mendieta |Jimena Alguacil Césari

Publicado el La denominada Agenda 2030, en la que se insertan los diecisiete Objetivos de Desarrollo Sostenible (ODS), está lejos de ser una mefistofélica estrategia. De hecho, constituye uno de los mayores triunfos del multilateralismo de los últimos tiempos .

Nov 14, 2023 | ascopubs.org | Joaquin Mateo |Karim Fizazi |Fred Saad |Neal Shore

In all subgroups assessed, olaparib improved outcomes versus abiraterone or enzalutamide for patients with mCRPC with BRCA alterations whose disease had progressed on previous NHA. Olaparib was associated with longer rPFS (hazard ratio [HR], 0.22 [95% CI, 0.15 to 0.32]) and OS (HR, 0.63 [95% CI, 0.42 to 0.95]) than control.

Nov 14, 2023 | brnw.ch | Joaquin Mateo |Karim Fizazi |Fred Saad |Neal Shore

Although multiple treatment options exist for patients with metastatic castration-resistant prostate cancer (mCRPC), outcomes remain poor, with clinical trials reporting median overall survival (OS) of approximately 3 years after diagnosis and life expectancy in real-world practice of closer to 2 years.1-4 Therefore, developing new strategies, including precision medicine approaches, to treat these patients is important.

Apr 28, 2023 | diarioresponsable.com | Joaquin Mateo

Apr 28, 2023 | diarioresponsable.com | Joaquin Mateo